• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

已故供体特征与肾脏移植结局。

Deceased Donor Characteristics and Kidney Transplant Outcomes.

机构信息

Department of Nephrology and Transplantation, University Hospitals Birmingham, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.

出版信息

Transpl Int. 2022 Aug 25;35:10482. doi: 10.3389/ti.2022.10482. eCollection 2022.

DOI:10.3389/ti.2022.10482
PMID:36090778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9452640/
Abstract

Kidney transplantation is the therapy of choice for people living with kidney failure who are suitable for surgery. However, the disparity between supply versus demand for organs means many either die or are removed from the waiting-list before receiving a kidney allograft. Reducing unnecessary discard of deceased donor kidneys is important to maximize utilization of a scarce and valuable resource but requires nuanced decision-making. Accepting kidneys from deceased donors with heterogenous characteristics for waitlisted kidney transplant candidates, often in the context of time-pressured decision-making, requires an understanding of the association between donor characteristics and kidney transplant outcomes. Deceased donor clinical factors can impact patient and/or kidney allograft survival but risk-versus-benefit deliberation must be balanced against the morbidity and mortality associated with remaining on the waiting-list. In this article, the association between deceased kidney donor characteristics and post kidney transplant outcomes for the recipient are reviewed. While translating this evidence to individual kidney transplant candidates is a challenge, emerging strategies to improve this process will be discussed. Fundamentally, tools and guidelines to inform decision-making when considering deceased donor kidney offers will be valuable to both professionals and patients.

摘要

肾移植是适合手术的肾衰竭患者的首选治疗方法。然而,器官的供需差距意味着许多人在接受肾移植之前要么死亡,要么从等待名单中被剔除。减少不必要的已故供体肾脏的丢弃对于最大限度地利用稀缺和宝贵的资源非常重要,但需要进行细致的决策。接受具有不同特征的已故供体肾脏用于等待肾移植候选者,通常是在时间紧迫的决策背景下,需要了解供体特征与肾移植结果之间的关联。已故供体的临床因素会影响患者和/或肾脏移植物的存活,但必须在与等待名单相关的发病率和死亡率之间权衡风险与收益。本文回顾了已故肾脏供体特征与受者肾移植后结果之间的关系。虽然将这一证据转化为个体肾移植候选者是一项挑战,但改善这一过程的新兴策略将被讨论。从根本上讲,在考虑已故供体肾脏供体时,提供决策的工具和指南对专业人士和患者都将是有价值的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/544bf08be3f4/ti-35-10482-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/175ca25b0459/ti-35-10482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/11bab4d6ba44/ti-35-10482-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/544bf08be3f4/ti-35-10482-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/175ca25b0459/ti-35-10482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/11bab4d6ba44/ti-35-10482-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1197/9452640/544bf08be3f4/ti-35-10482-g003.jpg

相似文献

1
Deceased Donor Characteristics and Kidney Transplant Outcomes.已故供体特征与肾脏移植结局。
Transpl Int. 2022 Aug 25;35:10482. doi: 10.3389/ti.2022.10482. eCollection 2022.
2
Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.接受或拒绝已故供体肾移植与肾移植候选人结局的关系。
JAMA Netw Open. 2019 Aug 2;2(8):e1910312. doi: 10.1001/jamanetworkopen.2019.10312.
3
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
4
Pediatric deceased donor renal transplantation: An approach to decision making I. Pediatric kidney allocation in the USA: The old and the new.小儿尸体供肾移植:决策方法 一、美国小儿肾脏分配:旧法与新法
Pediatr Transplant. 2015 Nov;19(7):776-84. doi: 10.1111/petr.12569. Epub 2015 Oct 1.
5
Impact of Extending Eligibility for Reinstatement of Waiting Time After Early Allograft Failure: A Decision Analysis.早期移植物失败后等待时间恢复资格延长的影响:决策分析。
Am J Kidney Dis. 2022 Mar;79(3):354-361. doi: 10.1053/j.ajkd.2021.07.023. Epub 2021 Sep 22.
6
Comparing the Net Benefits of Adult Deceased Donor Kidney Transplantation for a Patient on the Preemptive Waiting List vs a Patient Receiving Dialysis.比较预先等待名单上的患者与接受透析治疗的患者进行成人已故供体肾移植的净收益。
JAMA Netw Open. 2022 Jul 1;5(7):e2223325. doi: 10.1001/jamanetworkopen.2022.23325.
7
Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant.目前被列入等待名单的60岁以上的肾移植候选者中,有一半会在接受尸体供体移植前死亡。
Clin J Am Soc Nephrol. 2009 Jul;4(7):1239-45. doi: 10.2215/CJN.01280209. Epub 2009 Jun 18.
8
The 37-year kidney transplantation experience at Siriraj Hospital.诗里拉吉医院37年的肾脏移植经验。
Clin Transpl. 2010:141-8.
9
Whether or not to accept a deceased donor kidney offer for a pediatric patient.是否接受为一名儿科患者提供的已故捐赠者的肾脏。
Pediatr Nephrol. 2015 Sep;30(9):1529-36. doi: 10.1007/s00467-015-3139-x. Epub 2015 Jul 1.
10
Waiting for a kidney from a deceased donor: an interpretative phenomenological analysis.等待来自已故捐赠者的肾脏:一项解释现象学分析。
Psychol Health Med. 2016 Oct;21(7):836-44. doi: 10.1080/13548506.2015.1112415. Epub 2015 Nov 20.

引用本文的文献

1
LILRB3 genetic variation is associated with kidney transplant failure in African American recipients.LILRB3基因变异与非裔美国受者的肾移植失败有关。
Nat Med. 2025 May;31(5):1677-1687. doi: 10.1038/s41591-025-03568-z. Epub 2025 Mar 10.
2
Association of Cardiopulmonary Hemodynamics and Outcomes in Pulmonary Hypertension Following Kidney Transplantation: A Multicenter Retrospective Cohort Study.肾移植术后肺动脉高压患者心肺血流动力学与预后的关联:一项多中心回顾性队列研究
Chest. 2024 Dec;166(6):1499-1510. doi: 10.1016/j.chest.2024.08.013. Epub 2024 Aug 23.
3
Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection.

本文引用的文献

1
Risk Aversion, Organ Utilization and Changing Behavior.风险规避、器官利用与行为变化。
Transpl Int. 2022 Apr 7;35:10339. doi: 10.3389/ti.2022.10339. eCollection 2022.
2
Reconsidering Donor Race in Predicting Allograft and Patient Survival Among Kidney Transplant Recipients.重新考虑供者种族对肾移植受者移植肾和患者生存的预测作用。
Kidney360. 2021 Aug 19;2(11):1831-1835. doi: 10.34067/KID.0002932021. eCollection 2021 Nov 25.
3
Kidney Allocation Policy: Past, Present, and Future.肾脏分配政策:过去、现在和未来。
设计、队列特征及 KTD-Innov 研究的比较:肾移植排斥反应前瞻性多维生物标志物验证研究。
Eur J Epidemiol. 2024 May;39(5):549-564. doi: 10.1007/s10654-024-01112-w. Epub 2024 Apr 16.
4
Lower access to kidney transplantation for women in France is not explained by comorbidities and social deprivation.法国女性接受肾移植的机会较低,这与合并症和社会贫困无关。
Nephrol Dial Transplant. 2024 Sep 27;39(10):1613-1623. doi: 10.1093/ndt/gfae047.
5
Graft survival and mortality outcomes after kidney transplant in patients with lupus nephritis: a systematic review and meta-analysis.狼疮性肾炎患者肾移植后移植物存活率和死亡率结局:系统评价和荟萃分析。
Ren Fail. 2024 Dec;46(1):2296000. doi: 10.1080/0886022X.2023.2296000. Epub 2024 Jan 4.
6
The UK kidney donor risk index poorly predicts long-term transplant survival in paediatric kidney transplant recipients.英国肾脏供体风险指数对儿科肾脏移植受者的长期移植存活率预测效果不佳。
Front Immunol. 2023 Jun 2;14:1207145. doi: 10.3389/fimmu.2023.1207145. eCollection 2023.
7
Cold Storage Followed by Transplantation Induces Interferon-Gamma and STAT-1 in Kidney Grafts.冷藏后移植诱导肾移植物中干扰素-γ和 STAT-1 的表达。
Int J Mol Sci. 2023 Mar 13;24(6):5468. doi: 10.3390/ijms24065468.
Adv Chronic Kidney Dis. 2021 Nov;28(6):511-516. doi: 10.1053/j.ackd.2022.01.006.
4
Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis.等待肾衰移植患者接受移植与继续等待的生存情况:系统评价和荟萃分析。
BMJ. 2022 Mar 1;376:e068769. doi: 10.1136/bmj-2021-068769.
5
Reducing Kidney Discard With Artificial Intelligence Decision Support: the Need for a Transdisciplinary Systems Approach.利用人工智能决策支持减少肾脏丢弃:跨学科系统方法的必要性。
Curr Transplant Rep. 2021;8(4):263-271. doi: 10.1007/s40472-021-00351-0. Epub 2021 Nov 15.
6
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution.解读当前移植时代控制性循环死亡后扩大的供肾移植结局。呼吁谨慎。
Transpl Int. 2021 Dec;34(12):2494-2506. doi: 10.1111/tri.14131. Epub 2021 Oct 28.
7
Augmenting the Transplant Team With Artificial Intelligence: Toward Meaningful AI Use in Solid Organ Transplant.用人工智能增强移植团队:实现实体器官移植中人工智能的有意义应用。
Front Immunol. 2021 Jun 11;12:694222. doi: 10.3389/fimmu.2021.694222. eCollection 2021.
8
Development and validation of a risk index to predict kidney graft survival: the kidney transplant risk index.开发和验证一种预测肾移植存活率的风险指数:肾移植风险指数。
BMC Med Res Methodol. 2021 Jun 21;21(1):127. doi: 10.1186/s12874-021-01319-5.
9
Temporal trends in the quality of deceased donor kidneys and kidney transplant outcomes in Europe: an analysis by the ERA-EDTA Registry.欧洲死亡供体肾脏质量和肾移植结局的时间趋势:ERA-EDTA 登记处的分析。
Nephrol Dial Transplant. 2021 Dec 31;37(1):175-186. doi: 10.1093/ndt/gfab156.
10
Transplant outcomes using kidneys from high KDPI acute kidney injury donors.使用 KDPI 较高的急性肾损伤供者的肾脏进行移植的结果。
Clin Transplant. 2021 May;35(5):e14279. doi: 10.1111/ctr.14279. Epub 2021 Mar 31.